Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Accumulated Expenses (2024 - 2026)

Carlsmed filings provide 2 years of Accumulated Expenses readings, the most recent being $3.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 22.33% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 22.33% increase, with the full-year FY2025 number at $3.3 million, up 22.33% from a year prior.
  • Accumulated Expenses hit $3.3 million in Q4 2025 for Carlsmed, up from $3.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q4 2025 to a low of $2.7 million in Q4 2024.